BACKGROUND AND PURPOSE: The direct carotid exposure approach (DCEA) is a technical option for elderly patients with severe vessel tortuosity due to arteriosclerosis. We evaluated complications related to antiplatelet/anticoagulant management and compared the DCEA to standard transfemoral/transbrachial approaches (TFBA) in the treatment of unruptured intracranial aneurysms for elderly patients. METHODS: From August 2017 to August 2020, 52 patients (53 procedures) aged over 75 years with unruptured aneurysms in the anterior circulation were treated at our institution. All patients received dual antiplatelet drugs before the procedure. Eleven patients (21.2%) (12 procedures) were treated with the DCEA. The rest were treated with TFBA. The main indication of the DCEA was an unfavorable aortic arch or vessel tortuosity. Complications and the duration of the procedure were compared between the two groups. RESULTS: There were no significant differences between the two groups in age, aneurysm location, preoperative antiplatelet use, heparin use, or maximum activated clotting time (ACT) values. All endovascular treatments were successfully performed by DCEA. Among all parameters, the DCEA group had only bigger average aneurysm diameter (14 mm) and higher number of pipeline embolic device (PED) placement (58%). Time to the guiding-catheter placement was not significantly different between the groups (DCEA vs TFBA = 31.0 min vs 24.7 min, p = 0.178). No significant complications of DCEA, such as subcutaneous hematomas, were observed. . CONCLUSION: Even with the use of antiplatelet and anticoagulation therapy, the DCEA can be performed safely for unruptured aneurysms in elderly patients.
BACKGROUND AND PURPOSE: The direct carotid exposure approach (DCEA) is a technical option for elderly patients with severe vessel tortuosity due to arteriosclerosis. We evaluated complications related to antiplatelet/anticoagulant management and compared the DCEA to standard transfemoral/transbrachial approaches (TFBA) in the treatment of unruptured intracranial aneurysms for elderly patients. METHODS: From August 2017 to August 2020, 52 patients (53 procedures) aged over 75 years with unruptured aneurysms in the anterior circulation were treated at our institution. All patients received dual antiplatelet drugs before the procedure. Eleven patients (21.2%) (12 procedures) were treated with the DCEA. The rest were treated with TFBA. The main indication of the DCEA was an unfavorable aortic arch or vessel tortuosity. Complications and the duration of the procedure were compared between the two groups. RESULTS: There were no significant differences between the two groups in age, aneurysm location, preoperative antiplatelet use, heparin use, or maximum activated clotting time (ACT) values. All endovascular treatments were successfully performed by DCEA. Among all parameters, the DCEA group had only bigger average aneurysm diameter (14 mm) and higher number of pipeline embolic device (PED) placement (58%). Time to the guiding-catheter placement was not significantly different between the groups (DCEA vs TFBA = 31.0 min vs 24.7 min, p = 0.178). No significant complications of DCEA, such as subcutaneous hematomas, were observed. . CONCLUSION: Even with the use of antiplatelet and anticoagulation therapy, the DCEA can be performed safely for unruptured aneurysms in elderly patients.
Authors: Christian Dorfer; Harald Standhardt; Andreas Gruber; Heber Ferraz-Leite; Engelbert Knosp; Gerhard Bavinzski Journal: World Neurosurg Date: 2011-11-17 Impact factor: 2.104
Authors: Maxim Mokin; Kenneth V Snyder; Elad I Levy; L Nelson Hopkins; Adnan H Siddiqui Journal: J Neurointerv Surg Date: 2014-01-09 Impact factor: 5.836
Authors: K Nii; K Kazekawa; M Onizuka; H Aikawa; M Tsutsumi; M Tomokiyo; M Iko; T Kodama; S Matsubara; Y Go; A Tanaka Journal: AJNR Am J Neuroradiol Date: 2006-08 Impact factor: 3.825
Authors: Nestor R Gonzalez; Joshua R Dusick; Gary Duckwiler; Satoshi Tateshima; Reza Jahan; Neil A Martin; Fernando Viñuela Journal: Neurosurgery Date: 2010-04 Impact factor: 4.654
Authors: Adam Roche; Emma Griffin; Seamus Looby; Paul Brennan; Alan O'Hare; John Thornton; Karl Boyle; David Williams; Barry Moynihan; Sarah Power Journal: J Neurointerv Surg Date: 2019-04-06 Impact factor: 5.836